Using artificial sweeteners may disrupt the way the body handles sugar, increasing the risk of diabetes for some people, according to a new study published in the journal Nature. The research, conducted primarily on laboratory animals, suggests that artificial sweeteners, such as Splenda, Equal and NutraSweet, can change the bacteria that normally resides in the gut. When this happens, it disrupts how the body handles sugar in the diet, which can lead to increased blood sugar levels, a condition called glucose intolerance, which is a precursor to type 2 diabetes. Researchers say that it is too early to caution people ... Read More
Pharmaceutical 3240 articles
Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.
Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.
Medical safety specialists are concerned at the growing number of young children who are sickened or die from accidentally swallowing a relative’s prescription for a medication used to treat opioid drug addiction. For every 100,000 patients who are prescribed buprenorphine, 200 children are hospitalized – a rate more than four times higher than the second-most accidentally ingested medication, blood pressure mediation. The research is published in the current issue of the journal Pediatrics. Buprenorphine is a narcotic much like the drugs it is designed to help patients wean off, such as heroin or prescription painkillers. While it can produce typical ... Read More
Bayer’s dietary supplement Phillips’ Colon Health is making unsupported claims that it can prevent diarrhea, constipation, gas and bloating but the company does not have reliable scientific evidence to support those claims, according to the Department of Justice. Federal officials took aim at Bayer in a motion filed last week, referencing the company’s multimillion dollar marketing campaigns using both print and television advertisements featuring “the Colon Lady,” who asks people about their colon health. As a result, consumers have spent hundreds of millions of dollars on Phillips’ Colon Health, the motion claims. The government’s crackdown on Bayer stems from a ... Read More
Baxter International, Inc., is recalling one lot of potassium chloride injection because the drug packaging may contain units of gentamicin sulfate instead. Potassium chloride injection is used to treat potassium deficiency. Gentamicin sulfate is an antibacterial drug. This labeling error could result in a medication error or delay in therapy for patients who require high concentration of potassium chloride, the Food and Drug Administration (FDA) warned. The recall involves Lot #P318220, NDC # 0338-079-48 of potassium chloride Injection 10mEq per 100mL, with the product code 2B0826. Shipping cartons labeled for this specific lot number of potassium chloride injection may contain units ... Read More
Pfizer’s testosterone replacement treatment Depo-Testosterone has become the subject of lawsuits questioning the safety and efficacy of the drugs after reports of heart attacks, strokes and blood clots in patients treated with the hormone. The lawsuit filed on behalf of Alvaro Roman Gutierrez alleges that Pfizer and its unit Pharmacia & Upjohn Co. LLC, conducted a “disease mongering” campaign to exaggerate the problem of low testosterone levels in men in order to boost sales of Depo-Testosterone. Gutierrez claims that Pfizer and Pharmacia & Upjohn spent millions of dollars to promote its drug to consumers and, along with other drug companies not ... Read More
Whistleblower lawsuits accusing Merck of mumps vaccine deceptions will proceed to court, judge decides
Two lawsuits accusing Merck & Co. of lying about the efficacy of its mumps vaccines to keep competitors from introducing similar vaccines to the market will be proceed to trial after a federal judge in Pennsylvania refused to dismiss the suits. U.S. District Judge C. Darnell Jones II ruled that one of the lawsuits, filed by a pair of whistleblowers who worked as virologists for Merck, provided enough evidence that the pharmaceutical giant lied about the vaccine’s efficacy to the federal government. The judge also ruled that the other lawsuit, filed by a group of physicians and direct buyers, could ... Read More
A U.S. District judge has dismissed an antitrust lawsuit accusing drug makers Pfizer and Ranbaxy Laboratories of conspiring to delay sales of generic versions of their best selling cholesterol-lowering statin drug Lipitor. Judge Peter Sheridan said that the plaintiffs, retailers and distribution companies that bought Lipitor from Pfizer did not provide enough details to convince him that Pfizer and Ranbaxy had violated patent agreements. The lawsuit stems from a 2008 settlement of a patent settlement reached between Pfizer and Ranbaxy regarding Ranbaxy’s plan to make generic versions of Lipitor. Under that agreement, Pfizer agreed to drop damage claims against Ranbaxy, ... Read More
Keryx Biopharmaceuticals received Food and Drug Administration (FDA) clearance for its ferric citrate drug to treat complications with kidney disease, but the approval requires the drug company to add a warning to the safety label that using the drug can cause “iron overload,” which may require physician supervision while the patient is being treated. The drug is designed to treat dialysis patients with hyperphosphatemia, or elevated phosphates, which can lead to heart disease, bone density problems, and death. Keryx said that because ferric citrate can boost patients’ iron levels, dialysis patients who used anemia drugs and intravenous iron could reduce ... Read More
A new prescription diet pill has been given clearance by the Food and Drug Administration (FDA) for marketing in the United States. Contrave, made by Orexigen Therapeutics, is a combination of bupropion, an antidepressant that is also used for smoking cessation, and naltrexone, a drug used to treat drug and alcohol dependence. Contrave is approved for overweight or obese patients with a body mass index (BMI) of 30 or higher, as well as people with a BMI of 27 or higher with at least one other health issue such as diabetes. Patients treated with Contrave lost an average of 4.2 ... Read More
Children with a genetic cholesterol disorder can lower their risk of developing cardiovascular disease by taking cholesterol-lowering statins, according to a long-term European study. The research involved 194 children and teenagers with an inherited high cholesterol disorder known as familial hypercholesterolemia, a condition that affects about one in 500 people. People with this condition are at risk for premature hardening of the arteries (atherosclerosis). The children and teens were prescribed a statin drug and were followed for 10 years. Statins include the widely prescribed brand name drug Lipitor. According to researchers, taking statins prevented premature atherosclerosis. The younger a child ... Read More